Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of disposal of Euston House

14 Mar 2019 07:00

RNS Number : 7947S
Stenprop Limited
14 March 2019
 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

COMPLETION OF DISPOSAL OF EUSTON HOUSE IN LONDON FOR £95 MILLION

14 March 2019

Further to the announcement made by the Company on 10 January 2019, Stenprop announces that the sale of its Euston House office building in central London has now completed.

Stenprop has taken the strategic decision that its objective to deliver sustainable, growing income to shareholders is best achieved by becoming a specialised UK multi-let industrial (MLI) property company. This strategic repositioning means that Stenprop intends, over the next few years, to sell all its non-MLI assets and utilise the sale proceeds to build a focused UK MLI business.

Paul Arenson, CEO of Stenprop commented: "This is a significant sale for Stenprop, as Euston House is a material asset representing more than 10% by value of our portfolio. Being our last remaining central London office investment, it completes our divestment from the sector. The sale took place at a value of £95 million compared with the last reported independent valuation of £80.5 million, which was used to determine the September interim NAV of 142 pence per share.

"It also ensures that Stenprop will meet its stated milestones for the financial year ending 31 March 2019 of reducing its loan-to-value ratio to below 45% and increasing the overall MLI percentage of the portfolio to above 40%. Most significantly, the sale provides cash resources to fund additional MLI purchases in the financial year ending 31 March 2020, during which period Stenprop intends to reduce leverage further to below 40% and to acquire further MLI property so that MLI represents at least 60% of our portfolio by 31 March 2020."

 

For further information:

Stenprop Limited +44(0)20 3918 6600

Paul Arenson

Patsy Watson

Julian Carey

 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

 

Tavistock (PR Adviser) +44(0)20 7920 3150

James Whitmore

James Verstringhe

Kirsty Allan

 

Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050

(JSE Sponsor)

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISQXLFFKXFLBBL
Date   Source Headline
8th Feb 20197:00 amRNSNew debt facility
7th Feb 201911:00 amRNSResult of election for cash or scrip dividend
7th Feb 20197:00 amRNSTransaction in Own Shares
6th Feb 201911:00 amRNSDirectorate Change
1st Feb 20197:00 amRNSTransaction in Own Shares
28th Jan 20193:00 pmRNSUpdate To Dividend Announcement
25th Jan 20197:00 amRNSTransaction in Own Shares
23rd Jan 20193:00 pmRNSTransaction in own shares
23rd Jan 20197:01 amRNSTransaction in own shares
23rd Jan 20197:00 amRNSDealings in securities
15th Jan 20193:00 pmRNSDEALING BY AN ASSOCIATE OF A DIRECTOR
10th Jan 20194:35 pmRNSDisposal of Euston House
8th Jan 20198:30 amRNSScrip dividend finalisation
24th Dec 20187:00 amRNSAcquisition of multi-let industrial portfolio
20th Dec 20183:00 pmRNSELECTION TO RECEIVE A CASH OR SCRIP DIVIDEND
22nd Nov 20187:00 amRNSHalf-year Report
16th Nov 201811:00 amRNSNotice of Half Year Results
17th Oct 20182:00 pmRNSAcquisition of multi-let industrial estate
13th Sep 201810:00 amRNSResult of AGM
6th Sep 20182:00 pmRNSRealisation of performance fee
23rd Aug 20187:00 amRNSISSUE OF NEW SHARES
16th Aug 20182:00 pmRNSResult of election for cash or scrip dividend
7th Aug 20183:00 pmRNSTransaction in Own Shares
6th Aug 20189:00 amRNSAcquisition of multi-let industrial estate
2nd Aug 20189:00 amRNSTransaction in Own Shares
1st Aug 20189:00 amRNSTransaction in Own Shares
31st Jul 20182:30 pmRNSDirector Dealings Scrip Dividend
31st Jul 20189:00 amRNSTransaction in Own Shares
30th Jul 20189:00 amRNSTransaction in Own Shares
27th Jul 20182:00 pmRNSPUBLICATION OF ANNUAL REPORT AND NOTICE OF AGM
27th Jul 201811:01 amRNSACQUISITIONS OF TWO MULTI-LET INDUSTRIAL ESTATES
27th Jul 20189:00 amRNSTransaction in Own Shares
24th Jul 20182:00 pmRNSBlock listing application
20th Jul 20187:00 amRNSTransaction in Own Shares
19th Jul 20187:00 amRNSDISPOSAL OF SEVEN SWISS PROPERTIES
18th Jul 20189:45 amRNSDEALING IN SECURITIES BY A DIRECTOR OF THE COMPANY
17th Jul 20189:00 amRNSScrip Dividend
13th Jul 20187:00 amRNSACQUISITION OF MULTI-LET INDUSTRIAL ESTATE
10th Jul 201811:00 amRNSCASH DIVIDEND OR SCRIP DIVIDEND
22nd Jun 201811:00 amRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSIssue of Equity and Update to Rule 2.10
15th Nov 20104:49 pmRNSForm 8 (OPD) - SpiriTel plc
10th Nov 20105:32 pmRNSRule 2.10 Announcement
10th Nov 20105:06 pmRNSCancellation of Admission to Trading on AIM
10th Nov 20104:46 pmRNSDirectorate Change
21st Oct 201012:55 pmRNSResult of AGM
21st Oct 201012:55 pmRNSResult of AGM
28th Sep 20103:26 pmRNSNotice of AGM
27th Sep 20107:00 amRNSFinal Results
20th Sep 20107:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.